Literature DB >> 18853032

Sulfasalazine-induced DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms).

Renata Telles Rudge de Aquino1, Carmen Silvia Vieitas Vergueiro, Maria Elisa Ruffolo Magliari, Thais Helena Proença de Freitas.   

Abstract

CONTEXT: DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms) is a type of drug reaction commonly mistaken for a viral infection. It must be recognized promptly due to its high morbidity and 10% mortality rate. Few cases of DRESS syndrome induced by sulfasalazine have been reported in the literature. CASE REPORT: The case of a 47-year-old white Brazilian woman who developed DRESS syndrome eight weeks after starting a course of sulfasalazine for treatment of seronegative arthritis is reported. She presented a skin rash, fever, hepatitis, lymphadenopathy, eosinophilia and atypical lymphocytes. The causative drug was discontinued immediately, but she only improved after treatment with prednisone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853032     DOI: 10.1590/s1516-31802008000400006

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  7 in total

1.  Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.

Authors:  Neila Fathallah; Raoudha Slim; Salaheddine Rached; Wissem Hachfi; Amel Letaief; Chaker Ben Salem
Journal:  Int J Clin Pharm       Date:  2015-04-09

2.  A female with rash and facial swelling.

Authors:  Audrey Tan; Michael B Stone
Journal:  J Emerg Trauma Shock       Date:  2010-04

Review 3.  Hepatic manifestations of non-steroidal inflammatory bowel disease therapy.

Authors:  Robert Hirten; Keith Sultan; Ashby Thomas; David E Bernstein
Journal:  World J Hepatol       Date:  2015-11-28

4.  Drug Eruptions: An 8-year Study Including 106 Inpatients at a Dermatology Clinic in Turkey.

Authors:  Fatma Akpinar; Emine Dervis
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

5.  Sulfasalazine-induced drug rash with eosinophilia and systemic symptoms syndrome in a seronegative spondyloarthritis patient: A Case report.

Authors:  Naresh Sah; Balakeshwa Ramaiah; Raju Koneri
Journal:  Indian J Pharmacol       Date:  2021 Sep-Oct       Impact factor: 1.200

6.  Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.

Authors:  Sean Hammond; Anna Olsson-Brown; Sophie Grice; Andrew Gibson; Joshua Gardner; Jose Luis Castrejón-Flores; Carol Jolly; Benjamin Alexis Fisher; Neil Steven; Catherine Betts; Munir Pirmohamed; Xiaoli Meng; Dean John Naisbitt
Journal:  Toxicol Sci       Date:  2022-02-28       Impact factor: 4.849

7.  A New Case of DRESS Syndrome Induced by Sulfasalazine and Triggered by Amoxicillin.

Authors:  Francesco Girelli; Simone Bernardi; Lucia Gardelli; Bruna Bassi; Gianluca Parente; Alessandra Dubini; Luigi Serra; Maurizio Nizzoli
Journal:  Case Rep Rheumatol       Date:  2013-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.